New Vehicle Retail Sales Make a Roaring Comeback in the Third Quarter, Edmunds Forecasts

hafiz caem

SANTA MONICA, Calif., Sept. 24, 2020 /PRNewswire/ — The car shopping experts at Edmunds say that the third quarter represents a positive turning point for the automotive industry despite challenges presented by the coronavirus (COVID-19) pandemic. Edmunds analysts forecast that 3,850,707 new cars and trucks will be sold in the U.S., which reflects an 11% decrease from the third quarter of 2019 but a 30.6% increase compared to the second quarter of the year.

“Third-quarter sales make at least two things apparent: Most of the doomsday scenarios forecasted at the beginning of the pandemic fortunately did not hold true, and the American consumer stepped up to become one of the many heroes in this chapter of resilience for the automotive industry, ” said Jessica Caldwell, Edmunds’ executive director of insights. “Consistently lower interest rates encouraged new-car buyers — who were less likely to be financially hindered by the

Read More

Campbell Soup Q4 Net Sales Jump 18%, Forecast 5-7% Increase in Current Quarter; Target Price $59 in Best-Case

Campbell Soup Co, a US-centric packaged food company, reported an 18% surge in net sales in the fourth quarter and forecasts a 5-7% increase in the ongoing quarter as shoppers bought more Prego pasta sauces and Goldfish crackers during COVID-19 pandemic.

The food and snack processing company said its fourth-quarter net sales increased 18% and organic net sales increased 12% reflecting continued increased demand for products. The company said its earnings per share (EPS) from continuing operations were $0.28, increased from a loss of $0.02; Adjusted EPS of $0.63 increased 50%.

Campbell Soup’s full-year net sales and organic net sales increased 7% and EPS from continuing operations of $1.95 increased 24%. Given the uncertain operating environment due to the COVID-19 pandemic, the Company is providing guidance limited to the first quarter of fiscal 2021, the company said.

Campbell Soup’s shares traded slightly higher at $53.50 on Thursday. Also, the stock

Read More

PGIM Global High Yield Fund, Inc. Reports Unaudited Earnings and Financial Position for Quarter Ended July 31, 2020

NEWARK, N.J.–(BUSINESS WIRE)–PGIM Global High Yield Fund, Inc. (NYSE: GHY), (the “Fund”), a diversified, closed-end management investment company, announced today its unaudited investment results for the quarter ended July 31, 2020.

 

 

As of

July 31, 2020

 

As of

April 30, 2020

 

As of

July 31, 2019

Net Assets

$634,169,633

 

$552,885,411

 

$680,904,116

Loan Outstanding

$224,000,000

 

$179,000,000

 

$284,000,000

Shares Outstanding

40,923,879

 

40,923,879

 

40,923,879

Net Asset Value (“NAV”) Per Share (a)

$15.50

 

$13.51

 

$16.64

Market Price Per Share (b)

$13.18

 

$11.73

 

$14.52

Premium / (Discount) to NAV (c)

(15.0)%

 

(13.2)%

 

(12.7)%

 

 

 

 

 

 

Undistributed / (Overdistributed) Net Investment Income (d)

$3,042,733

 

$1,158,418

 

$5,569,839

Undistributed / (Overdistributed) Net Investment Income Per Share (e)

$0.07

 

$0.03

 

$0.14

 

 

 

 

 

 

 

Quarter Ended

July 31, 2020

 

Quarter Ended

April 30, 2020

 

Quarter Ended

July 31, 2019

Quarterly Earnings

 

 

 

 

 

Net Investment Income

$9,269,657

 

$10,377,176

 

$12,103,555

Net Realized and Unrealized Gain (Loss)

$84,905,587

 

($123,952,384)

 

$12,441,715

Net Increase / (Decrease) in Net

Read More

Immatics Announces Second Quarter 2020 Financial Results and Business Update

The MarketWatch News Department was not involved in the creation of this content.

Tuebingen, Germany and Houston, TX, Sep 03, 2020 (GLOBE NEWSWIRE via COMTEX) —
Tuebingen, Germany and Houston, TX, Sept. 03, 2020 (GLOBE NEWSWIRE) —

  • Completed merger with ARYA Life Science Acquisition Corp. and subsequent NASDAQ listing with proceeds from the transaction totaling $253 million (EUR226 million1) in July 2020.
  • At the closing of the transaction, cash and cash equivalents amounted to $322 million (EUR288 million1) enabling Immatics to fund operating expenses and capital expenditure requirements for at least 36 months.
  • Expanded ACTengine(R) clinical programs into Europe with first patient treated with genetically engineered T cell product candidate IMA202 in August 2020; regulatory approval by Paul-Ehrlich-Institute to begin phase I clinical trial with product candidate IMA203 in Germany and to open additional clinical trial sites in the EU.
  • Expanded leadership team with appointment of
Read More

Apogee Enterprises to Report Fiscal 2021 Second Quarter Financial Results

Apogee Enterprises, Inc. (Nasdaq: APOG) will report its fiscal 2021 second quarter results on Thursday, September 17, 2020 before the market opens. The company will also host a conference call to discuss its financial results and provide a business update. This conference call will be webcast beginning at 8:00 a.m. Central Time, on September 17, 2020.

Access to the webcast will be available through the Investors section of the company’s website at https://www.apog.com/events-and-presentations. For those unable to listen to the live webcast, a replay will be available on the company’s website.

About Apogee Enterprises, Inc.

Apogee Enterprises, Inc. (Nasdaq: APOG) delivers distinctive solutions for enclosing commercial buildings and framing art. Headquartered in Minneapolis, MN, we are a leader in architectural products and services, providing architectural glass, aluminum framing systems and installation services for buildings, as well as value-added glass and acrylic for custom picture framing and displays. For more information,

Read More

iTeos Reports Second Quarter 2020 Financial Results and Provides Business Update

– July 2020 IPO provided $210.6 million in net proceeds and extends cash runway into 2023 –

– EOS-850 A2AR antagonist and EOS-448 FCgR-enabled anti-TIGIT antibody continue to progress in clinical trials –

CAMBRIDGE, Mass. and GOSSELIES, Belgium, Sept. 01, 2020 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, today reported financial results for the second quarter ended June 30, 2020 and recent business highlights.

“The completion of our successful IPO in July was a major milestone for iTeos and further supports the advancement of our highly differentiated immunotherapy pipeline, including our two lead product candidates, our adenosine A2a receptor antagonist, EOS-850, and TIGIT antagonist, EOS-448,” said Michel Detheux, PhD, President and Chief Executive Officer of iTeos. “With trials ongoing for our two lead product candidates, we anticipate that 2021

Read More

Copart Reports Fourth Quarter Fiscal 2020 Financial Results

Copart, Inc. (NASDAQ: CPRT) today reported financial results for the quarter and year ended July 31, 2020.

For the three months ended July 31, 2020, revenue, gross profit, and net income were $525.7 million, $250.4 million, and $165.5 million, respectively. These represent a decrease in revenue of $16.9 million, or 3.1%; an increase in gross profit of $7.8 million, or 3.2%; and an increase in net income of $12.0 million, or 7.8%, respectively, from the same period last year. Fully diluted earnings per share for the three months ended July 31, 2020 were $0.69 compared to $0.64 last year, an increase of 7.8%.

For the year ended July 31, 2020, revenue, gross profit, and net income were $2.2 billion, $1.0 billion, and $699.9 million, respectively. These represent an increase in revenue of $163.6 million, or 8.0%; an increase in gross profit of $109.5 million, or 12.2%; and an increase in

Read More

Fortress Technologies Inc. Announces Second Quarter 2020 Financial Results

The MarketWatch News Department was not involved in the creation of this content.

VANCOUVER, British Columbia, Aug 31, 2020 (GLOBE NEWSWIRE via COMTEX) —
VANCOUVER, British Columbia, Aug. 31, 2020 (GLOBE NEWSWIRE) — Fortress Technologies Inc. (“Fortress” or the “Company“) (TSXV: FORT), a well-capitalized company currently evaluating emerging opportunities in technology sectors, reports its results of operations for the second quarter and six months period ended June 30, 2020 (“Q2 2020“). For the full condensed consolidated interim financial statements and management discussion & analysis for the Q2 2020, please visit the Company’s profile on the System for Electronic Document Analysis and Retrieval (“SEDAR“) at www.sedar.com.

Six-Months Ended June 30, 2020

“We are pleased to report revenue of $572,046 and net income of $95,188 for the first six months of 2020,” said Aydin Kilic, CEO of Fortress.

“Fortress is in a strong financial

Read More

Cuda Oil and Gas Inc. Announces Second Quarter Financial and Operating Results

Cuda” or the “Company“) announces its financial and operating results for the three and six months ended June 30, 2020. Cuda’s unaudited interim condensed consolidated financial statements and related management’s discussion and analysis (“MD&A”) as at and for the periods ended June 30, 2020 and June 2019, are available under the Company’s profile on the SEDAR website at www.sedar.com. Selected financial and operating information for the three and six months ended June 30, 2020 appear below and should be read in conjunction with the related financial statements and MD&A.” data-reactid=”19″Calgary, Alberta–(Newsfile Corp. – September 1, 2020) – Cuda Oil and Gas Inc. (TSXV: CUDA) (“Cuda” or the “Company“) announces its financial and operating results for the three and six months ended June 30, 2020. Cuda’s unaudited interim condensed consolidated financial statements and related management’s discussion and analysis (“MD&A”) as at and

Read More